Regulation of the A3 Adenosine Receptor Gene in Vascular Smooth Muscle Cells: Role of a cAMP and GATA Element
Authors:
- 1 November 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 62 (5) , 1167-1176
Abstract
In previous studies, we reported that the level of expression of the adenylyl cyclase inhibitory A3 adenosine receptor (AR) impacts vascular tone and that rat vascular smooth muscle cells (VSMCs) coexpress the A3 AR and the adenylyl cyclase stimulatory A2a- and A2b-type ARs. In the current study, we investigated the regulation of expression of the A3 AR gene, focusing on sequences conserved in the mouse and human promoters. Transient transfection of primary cultures of rat VSMCs, using the mouse A3 AR promoter, shows that mutation of a conserved cAMP response element (CRE) significantly up-regulates promoter activity in first passage cells, whereas mutation of a conserved GATA site reduces promoter activity. This suggests that an inhibitory protein binds the CRE, whereas an enhancing factor binds the GATA sequence. Electrophoretic mobility shift assays (EMSAs) indicate that the putative CRE and GATA sites indeed bind cAMP response element modulator 1/c-Jun and the GATA6 protein, respectively. A3 AR promoter activity is significantly up-regulated in the presence of forskolin, the nonselective agonist 5′-(N-ethylcarboxamido)adenosine, or the A2a AR agonist 4-[2-[[6-amino-9(N-ethyl-β-d-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]benzenepro- panoic acid (CGS21680), reaching levels similar to those of the A3 AR promoter bearing a mutated CRE. EMSA indicates that in the presence of forskolin the binding to the CRE is inhibited, suggesting that cAMP elevation disturbs the formation of an inhibitory complex on the CRE. Finally, semiquantitative reverse transcription-polymerase chain reaction analysis reveals that endogenous A3 AR mRNA is elevated in response to forskolin. Our findings suggest the presence of a mechanism by which cAMP might control its own level in cells via regulation of genes involved in modulation of adenylyl cyclase activity.Keywords
This publication has 40 references indexed in Scilit:
- Regulation of the ANF and BNP promoters by GATA factors: Lessons learned for cardiac transcriptionCanadian Journal of Physiology and Pharmacology, 2001
- A p300 Protein as a Coactivator of GATA-6 in the Transcription of the Smooth Muscle-Myosin Heavy Chain GeneJournal of Biological Chemistry, 2000
- Characterization of the Mouse A3 Adenosine Receptor Gene: Exon/Intron Organization and Promoter ActivityGenomics, 1999
- The HumanGATA-6Gene: Structure, Chromosomal Location, and Regulation of Expression by Tissue-Specific and Mitogen-Responsive SignalsGenomics, 1996
- The Species-Specific Differences in the cAMP Regulation of the Tissue-Type Plasminogen Activator Gene between Rat, Mouse and Human is Caused by a One-Nucleotide Substitution in the cAMP-Responsive Element of the PromotersEuropean Journal of Biochemistry, 1995
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressorCell, 1993
- Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtypeMolecular Endocrinology, 1992
- Molecular cloning of a novel putative G‐protein coupled receptor expressed during rat spermiogenesisFEBS Letters, 1991
- Elastin mRNA levels and insoluble elastin accumulation in neonatal rat smooth muscle cell culturesBiochemistry, 1988